Post-inflammatory hyperpigmentation
Conditions
Interventions
Hyperpigmentation
Pain model
Sponsors
Centre for Human Drug Research
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: 1. Healthy male and female subjects, who participated in one of these studies CHDR0729, CHDR1311, CHDR1422, CHDR1425, CHDR1431 or CHDR1440. 2. Able to participate and willing to give written informed consent and to comply with the study restrictions
Exclusion criteria
Exclusion criteria: 1. Legal incapacity or inability to understand or comply with the requirements of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of hyperpigmented lesions by * Clinical scoring * Multispectral imaging * UV photography * Cross-polarized photography Hyperpigmented lesion size and severity as determined by * Clinical assessment with caliper * Multispectral imaging * UV photography * Cross-polarized photography Changes in lesion size and severity of hyperpigmented lesions over time | — |
Countries
The Netherlands
Outcome results
None listed